Dermatology Outlook 2011 - H E A LT H C A R E The...

Info iconThis preview shows pages 1–5. Sign up to view the full content.

View Full Document Right Arrow Icon
HEALTHCARE The Dermatology Market Outlook to 2011 By Fox Analytics Table of Contents
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
ii Fox Analytics Fox Analytics brings together experienced private consultants working in the field of market research, analysis, modeling and forecasting in order to deliver custom solutions, insights and analysis in pharmaceuticals and healthcare markets. Copyright © 2007 Business Insights Ltd This Management Report is published by Business Insights Ltd. All rights reserved. Reproduction or redistribution of this Management Report in any form for any purpose is expressly prohibited without the prior consent of Business Insights Ltd. The views expressed in this Management Report are those of the publisher, not of Business Insights. Business Insights Ltd accepts no liability for the accuracy or completeness of the information, advice or comment contained in this Management Report nor for any actions taken in reliance thereon. While information, advice or comment is believed to be correct at the time of publication, no responsibility can be accepted by Business Insights Ltd for its completeness or accuracy.
Background image of page 2
iii Table of Contents The Dermatology Market Outlook to 2011 Executive Summary 13 Patient potential 13 Global market analysis 14 Pipeline analysis 15 Competitive landscape 16 Chapter 1 Patient potential 19 Summary 19 Introduction 20 Acne 21 Overview 21 Diagnosis, treatment and management 21 Epidemiology 24 Forecast epidemiology 26 Psoriasis 28 Overview 28 Diagnosis, treatment and management 29 Epidemiology 31 Forecast epidemiology 32 Infectious diseases of the skin 34 Overview 34 Bacterial infections of the skin 34 Fungal infections of the skin 36 Viral infections of the skin 37 Diagnosis, treatment and management 38 Epidemiology 39 Viral skin infections 39 Fungal skin infections 40 Bacterial skin infections 41 Forecast epidemiology 42 Viral skin infections 42 Fungal skin infections 43 Bacterial skin infections 45
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
iv Dermatitis 46 Overview 46 Diagnosis, treatment and management 46 Epidemiology 47 Forecast epidemiology 48 Rosacea 50 Overview 50 Diagnosis, treatment and management 50 Epidemiology 51 Forecast epidemiology 52 Chapter 2 Global market analysis 55 Summary 55 Introduction 56 Market analysis by country 56 Licensing trends 58 Market analysis by drug class 59 Leading brands dynamics 62 Key events in the dermatology market 64 Continued approvals for biologic agents in the treatment of psoriasis 64 Black box warnings for Elidel and Protopic 65 Safety concerns over Roaccutane gain more traction 65 Acne treatments 66 Market analysis by drug class 66 Competitive dynamics of acne treatments 66 Leading acne treatment brands 68 Oral acne treatments market analysis 71 Market dynamics 71 Key brands analysis 73 Topical acne treatments market analysis 78 Market dynamics 78 Key brands analysis 80 Acne treatment sales forecasts to 2011 83 Psoriasis treatments 84 Market analysis by drug class 84 Competitive dynamics of psoriasis treatment classes 85 Leading brands of psoriasis treatments
Background image of page 4
Image of page 5
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 10

Dermatology Outlook 2011 - H E A LT H C A R E The...

This preview shows document pages 1 - 5. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online